Cidara Therapeutics (CDTX) Stock Forecast, Price Target & Predictions
CDTX Stock Forecast
Cidara Therapeutics stock forecast is as follows: an average price target of $24.00 (represents a 37.54% upside from CDTX’s last price of $17.45) and a rating consensus of 'Buy', based on 2 wall street analysts offering a 1-year stock forecast.
CDTX Price Target
CDTX Analyst Ratings
Buy
Cidara Therapeutics Price Target by Analyst
Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
---|---|---|---|---|---|---|
Aug 14, 2024 | Ed Arce | H.C. Wainwright | $24.00 | $12.86 | 86.63% | 37.54% |
10
Cidara Therapeutics Price Target by Period
1M | 3M | 12M | |
---|---|---|---|
# Anlaysts | - | - | 1 |
Avg Price Target | - | - | $24.00 |
Last Closing Price | $17.45 | $17.45 | $17.45 |
Upside/Downside | -100.00% | -100.00% | 37.54% |
Analyst Ratings Upgrades/Downgrades
Date | Company | Previous Rating | New Rating | Rating Change |
---|---|---|---|---|
Aug 14, 2024 | H.C. Wainwright | - | Buy | Upgrade |
May 12, 2022 | Needham | Buy | Buy | Hold |
10
Cidara Therapeutics Financial Forecast
Cidara Therapeutics Revenue Forecast
Quarter
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - | - | - | - | $12.72M | $7.61M | $25.99M | $10.22M | $40.74M | $6.22M | $7.11M | $7.22M | $7.08M | $32.86M | $2.41M | $3.73M | $2.42M | $3.39M | $2.53M | $1.81M | $19.10M |
Avg Forecast | - | - | - | - | $300.00K | $433.33K | $1.30M | $9.03M | $13.95M | $8.14M | $11.55M | $18.68M | $10.57M | $28.35M | $6.21M | $5.89M | $4.31M | $2.94M | $12.13M | $7.88M | $12.95M | $4.89M | $5.29M | $2.25M | $3.63M | $7.50M |
High Forecast | - | - | - | - | $300.00K | $433.33K | $1.30M | $9.03M | $13.95M | $8.14M | $11.55M | $18.68M | $10.57M | $28.35M | $6.21M | $5.89M | $4.31M | $2.94M | $12.13M | $7.88M | $12.95M | $4.89M | $5.29M | $2.25M | $3.63M | $7.50M |
Low Forecast | - | - | - | - | $300.00K | $433.33K | $1.30M | $9.03M | $13.95M | $8.14M | $11.55M | $18.68M | $10.57M | $28.35M | $6.21M | $5.89M | $4.31M | $2.94M | $12.13M | $7.88M | $12.95M | $4.89M | $5.29M | $2.25M | $3.63M | $7.50M |
# Analysts | - | - | - | - | 2 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Surprise % | - | - | - | - | - | - | - | - | - | 1.56% | 0.66% | 1.39% | 0.97% | 1.44% | 1.00% | 1.21% | 1.68% | 2.41% | 2.71% | 0.31% | 0.29% | 0.49% | 0.64% | 1.12% | 0.50% | 2.55% |
Forecast
Cidara Therapeutics EBITDA Forecast
Quarter
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | - | - | - | - | 2 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
EBITDA | - | - | - | - | - | - | - | - | - | $-8.55M | $-12.83M | $2.98M | $-13.27M | $15.23M | $-12.81M | $-17.96M | $-18.19M | $-17.99M | $10.82M | $-18.23M | $-21.57M | $-17.56M | $-18.23M | $-14.47M | $-13.95M | $3.12M |
Avg Forecast | - | - | - | - | $-225.15K | $-325.22K | $-975.67K | $-16.79M | $-10.47M | $-6.11M | $-8.67M | $-17.95M | $-17.15M | $-20.95M | $-4.59M | $-19.20M | $-3.19M | $-2.17M | $-8.96M | $-10.03M | $-9.57M | $-3.61M | $-3.91M | $-9.36M | $-2.69M | $-5.54M |
High Forecast | - | - | - | - | $-225.15K | $-325.22K | $-975.67K | $-13.43M | $-10.47M | $-6.11M | $-8.67M | $-14.36M | $-13.72M | $-20.95M | $-4.59M | $-15.36M | $-3.19M | $-2.17M | $-8.96M | $-8.02M | $-9.57M | $-3.61M | $-3.91M | $-7.49M | $-2.69M | $-5.54M |
Low Forecast | - | - | - | - | $-225.15K | $-325.22K | $-975.67K | $-20.15M | $-10.47M | $-6.11M | $-8.67M | $-21.55M | $-20.58M | $-20.95M | $-4.59M | $-23.04M | $-3.19M | $-2.17M | $-8.96M | $-12.04M | $-9.57M | $-3.61M | $-3.91M | $-11.23M | $-2.69M | $-5.54M |
Surprise % | - | - | - | - | - | - | - | - | - | 1.40% | 1.48% | -0.17% | 0.77% | -0.73% | 2.79% | 0.94% | 5.71% | 8.27% | -1.21% | 1.82% | 2.25% | 4.86% | 4.67% | 1.55% | 5.19% | -0.56% |
Forecast
Cidara Therapeutics Net Income Forecast
Quarter
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | - | - | - | - | 2 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Net Income | - | - | - | - | - | - | - | - | - | $-8.17M | $-12.36M | $3.21M | $-13.38M | $14.98M | $-13.13M | $-18.30M | $-16.84M | $-18.08M | $10.71M | $-18.29M | $-21.63M | $-17.63M | $-18.31M | $-14.54M | $-14.02M | $3.04M |
Avg Forecast | $-10.19M | $-22.69M | $-33.43M | $-33.96M | $-24.18M | $-27.75M | $-26.77M | $-17.08M | $-9.80M | $-19.59M | $-16.98M | $-18.27M | $-17.21M | $-547.65K | $-25.56M | $-19.54M | $-29.66M | $-33.01M | $-19.78M | $-10.06M | $-21.91M | $-36.83M | $-25.64M | $-9.41M | $-39.47M | $-51.41M |
High Forecast | $-10.19M | $-22.69M | $-33.43M | $-33.96M | $-24.18M | $-27.75M | $-26.77M | $-13.67M | $-9.80M | $-19.59M | $-16.98M | $-14.62M | $-13.76M | $-547.65K | $-25.56M | $-15.63M | $-29.66M | $-33.01M | $-19.78M | $-8.05M | $-21.91M | $-36.83M | $-25.64M | $-7.53M | $-39.47M | $-51.41M |
Low Forecast | $-10.19M | $-22.69M | $-33.43M | $-33.96M | $-24.18M | $-27.75M | $-26.77M | $-20.50M | $-9.80M | $-19.59M | $-16.98M | $-21.93M | $-20.65M | $-547.65K | $-25.56M | $-23.45M | $-29.66M | $-33.01M | $-19.78M | $-12.07M | $-21.91M | $-36.83M | $-25.64M | $-11.29M | $-39.47M | $-51.41M |
Surprise % | - | - | - | - | - | - | - | - | - | 0.42% | 0.73% | -0.18% | 0.78% | -27.35% | 0.51% | 0.94% | 0.57% | 0.55% | -0.54% | 1.82% | 0.99% | 0.48% | 0.71% | 1.55% | 0.36% | -0.06% |
Forecast
Cidara Therapeutics SG&A Forecast
Quarter
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | - | - | - | - | 2 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
SG&A | - | - | - | - | - | - | - | - | - | $3.56M | $3.31M | $4.30M | $3.43M | $5.78M | $4.07M | $5.20M | $4.98M | $4.61M | $4.37M | $4.78M | $4.15M | $3.69M | $3.97M | $4.09M | $4.41M | $4.57M |
Avg Forecast | - | - | - | - | $182.78K | $264.02K | $792.07K | $4.86M | $8.50M | $4.96M | $7.03M | $5.20M | $3.30M | $17.27M | $3.78M | $5.56M | $2.63M | $1.79M | $7.39M | $2.63M | $7.89M | $2.98M | $3.22M | $1.37M | $2.21M | $4.57M |
High Forecast | - | - | - | - | $182.78K | $264.02K | $792.07K | $5.84M | $8.50M | $4.96M | $7.03M | $6.24M | $3.96M | $17.27M | $3.78M | $6.68M | $2.63M | $1.79M | $7.39M | $3.16M | $7.89M | $2.98M | $3.22M | $1.37M | $2.21M | $4.57M |
Low Forecast | - | - | - | - | $182.78K | $264.02K | $792.07K | $3.89M | $8.50M | $4.96M | $7.03M | $4.16M | $2.64M | $17.27M | $3.78M | $4.45M | $2.63M | $1.79M | $7.39M | $2.10M | $7.89M | $2.98M | $3.22M | $1.37M | $2.21M | $4.57M |
Surprise % | - | - | - | - | - | - | - | - | - | 0.72% | 0.47% | 0.83% | 1.04% | 0.33% | 1.08% | 0.94% | 1.90% | 2.57% | 0.59% | 1.82% | 0.53% | 1.24% | 1.23% | 2.99% | 1.99% | 1.00% |
Forecast
Cidara Therapeutics EPS Forecast
Quarter
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | - | - | - | - | 2 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
EPS | - | - | - | - | - | - | - | - | - | $-0.09 | $-0.14 | $0.03 | $-0.19 | $0.17 | $-0.19 | $-0.27 | $-0.26 | $-0.37 | $0.18 | $-0.39 | $-0.50 | $-0.41 | $-0.45 | $-0.46 | $-0.42 | $0.08 |
Avg Forecast | $-1.56 | $-3.48 | $-5.12 | $-5.20 | $-3.70 | $-4.25 | $-4.10 | $-2.39 | $-1.50 | $-3.00 | $-2.60 | $-0.73 | $-2.93 | $-0.12 | $-5.60 | $-5.56 | $-6.50 | $-7.23 | $-4.33 | $-6.70 | $-4.80 | $-8.07 | $-5.62 | $-6.80 | $-8.65 | $-11.27 |
High Forecast | $-1.56 | $-3.48 | $-5.12 | $-5.20 | $-3.70 | $-4.25 | $-4.10 | $-2.39 | $-1.50 | $-3.00 | $-2.60 | $-0.73 | $-2.93 | $-0.12 | $-5.60 | $-5.56 | $-6.50 | $-7.23 | $-4.33 | $-6.70 | $-4.80 | $-8.07 | $-5.62 | $-6.80 | $-8.65 | $-11.27 |
Low Forecast | $-1.56 | $-3.48 | $-5.12 | $-5.20 | $-3.70 | $-4.25 | $-4.10 | $-2.39 | $-1.50 | $-3.00 | $-2.60 | $-0.73 | $-2.93 | $-0.12 | $-5.60 | $-5.56 | $-6.50 | $-7.23 | $-4.33 | $-6.70 | $-4.80 | $-8.07 | $-5.62 | $-6.80 | $-8.65 | $-11.27 |
Surprise % | - | - | - | - | - | - | - | - | - | 0.03% | 0.05% | -0.04% | 0.06% | -1.42% | 0.03% | 0.05% | 0.04% | 0.05% | -0.04% | 0.06% | 0.10% | 0.05% | 0.08% | 0.07% | 0.05% | -0.01% |
Forecast